Kristopher Hanson is SVP and General Counsel of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 8,463 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 20, 2022, when has been sold 4,831 shares (Common Stock) at a price of $0.68 per share, resulting in proceeds of $3,285. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.46K
0% 3M change
0% 12M change
Total Value Held $0

Kristopher Hanson Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2022
BUY
Grant, award, or other acquisition
$3,285 $0.68 p/Share
4,831 Added 36.34%
8,463 Common Stock
Nov 19 2021
BUY
Grant, award, or other acquisition
$3,105 $2.01 p/Share
1,545 Added 29.84%
3,632 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
$3,046 $2.8 p/Share
1,088 Added 34.27%
2,087 Common Stock
Nov 20 2020
BUY
Grant, award, or other acquisition
$2,997 $3.0 p/Share
999 Added 50.0%
999 Common Stock
KH

Kristopher Hanson

SVP and General Counsel
Malvern, PA

Track Institutional and Insider Activities on PHAS

Follow PhaseBio Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

News

Receive news related to PhaseBio Pharmaceuticals Inc

Track Activities on PHAS